NLRP3 and major depressive disorder: Zhang et al. found that CUMS activated the NLRP3 inflammasome and increased IL-1β content in rat hippocampus, and administering the NLRP3 inhibitor VX765 significantly alleviated the neuroinflammation and depression-like behavior in the animals [50].